Journal article
Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension
- Abstract:
- NCT02526160.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 2.0MB, Terms of use)
-
- Publisher copy:
- 10.1136/rmdopen-2021-001714
- Publication website:
- https://scholarworks.iupui.edu/bitstream/1805/31986/1/rmdopen-2021-001714.pdf
Authors
- Publisher:
- BMJ Publishing Group
- Journal:
- RMD Open: Rheumatic and Musculoskeletal Diseases More from this journal
- Volume:
- 7
- Issue:
- 3
- Pages:
- e001714-e001714
- Publication date:
- 2021-09-21
- Acceptance date:
- 2021-08-16
- DOI:
- EISSN:
-
2056-5933
- ISSN:
-
2056-5933
- Language:
-
English
- Keywords:
- Pubs id:
-
1196551
- Local pid:
-
pubs:1196551
- Source identifiers:
-
W3201583035
- Deposit date:
-
2026-03-26
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2021
If you are the owner of this record, you can report an update to it here: Report update to this record